ELK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.134400E-01
Normal-vs-Stage2
9.720400E-01
Normal-vs-Stage3
3.731800E-01
Normal-vs-Stage4
9.182400E-01
Stage1-vs-Stage2
4.526400E-01
Stage1-vs-Stage3
4.436200E-01
Stage1-vs-Stage4
4.688400E-01
Stage2-vs-Stage3
1.850580E-01
Stage2-vs-Stage4
9.112600E-01
Stage3-vs-Stage4
3.343200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.439800E-01
Normal-vs-AfricanAmerican
7.758400E-01
Normal-vs-Asian
7.237800E-01
Caucasian-vs-AfricanAmerican
6.079800E-01
Caucasian-vs-Asian
6.794200E-01
AfricanAmerican-vs-Asian
3.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.548400E-01
Normal-vs-Female
9.068000E-01
Male-vs-Female
2.438200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.726600E-01
Normal-vs-Age(41-60Yrs)
5.122000E-01
Normal-vs-Age(61-80Yrs)
7.234400E-01
Normal-vs-Age(81-100Yrs)
4.687800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.902400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.646000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.636000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.365500E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.477600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.642200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.861000E-01
Normal-vs-Daily Drinker
6.240200E-01
Normal-vs-Weekly Drinker
7.792600E-01
Normal-vs-Occasional Drinker
8.772200E-01
Normal-vs-Social Drinker
7.190800E-01
Non Drinker-vs-Daily Drinker
7.539800E-01
Non Drinker-vs-Weekly Drinker
1.306190E-01
Non Drinker-vs-Occasional Drinker
3.770600E-01
Non Drinker-vs-Social Drinker
8.807800E-02
Daily Drinker-vs-Weekly Drinker
2.470400E-01
Daily Drinker-vs-Occasional Drinker
5.194000E-01
Daily Drinker-vs-Social Drinker
1.196180E-01
Weekly Drinker-vs-Occasional Drinker
4.524600E-01
Weekly Drinker-vs-Social Drinker
9.580000E-01
Occasional Drinker-vs-Social Drinker
3.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.701200E-01
Normal-vs-Grade 2
8.857600E-01
Normal-vs-Grade 3
8.596400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.223790E-03
Grade 1-vs-Grade 3
1.878010E-02
Grade 1-vs-Grade 4
7.701200E-01
Grade 2-vs-Grade 3
3.881000E-01
Grade 2-vs-Grade 4
8.857600E-01
Grade 3-vs-Grade 4
8.596400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.677200E-01
Normal-vs-NonDiabetic
9.021000E-01
Diabetic-vs-NonDiabetic
8.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.289200E-01
Normal-vs-NoPancreatitis
8.506800E-01
Pancreatitis-vs-NoPancreatitis
3.203800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.520400E-01
Normal-vs-N1
9.501400E-01
N0-vs-N1
2.378400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.629200E-01
Normal-vs-TP53-NonMutant
5.115800E-01
TP53-Mutant-vs-TP53-NonMutant
2.454300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
